Companies / Kalaris Therapeutics, Inc. / Activity
Activity — Kalaris Therapeutics, Inc.
13 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Akkaraju Srinivas Director | Buy | Common Stock | $5.00M | +480K +31.99% | 1,979,847 8.32% of shares | high |
| May 20, 2026 | Akkaraju Srinivas Director | Buy | Common Stock | $1.18M | +244K +12.34% | 2,224,147 9.34% of shares | high |
| Mar 20, 2026 | Hagen Brett R Executive | Sell | Common Stock | $12.9K | -2K -100.00% | 0 0.00% of shares | low |
| May 20, 2026 | Akkaraju Srinivas Director | Other | Common Stock | $0 | +4K +29.93% | 19,408 0.08% of shares | low |
| May 20, 2026 | Akkaraju Srinivas Director | Other | Common Stock | $0 | +15K | 14,937 0.06% of shares | low |
| May 20, 2026 | Akkaraju Srinivas Director | Other | Common Stock | $0 | -67K -0.62% | 10,657,028 44.77% of shares | low |
| Jun 3, 2026 | Adamis Anthony P Director | Grant | Stock Option (Right to Buy) | — | +9K | 9,000 0.04% of shares | low |
| Jun 3, 2026 | Akkaraju Srinivas Director | Grant | Stock Option (Right to Buy) | — | +9K | 9,000 0.04% of shares | low |
| Jun 3, 2026 | Patterson Leone D Director | Grant | Stock Option (Right to Buy) | — | +9K | 9,000 0.04% of shares | low |
| Mar 19, 2026 | Gall Matthew Executive | Grant | Stock Option (Right to Buy) | — | +95K | 95,000 0.40% of shares | low |
| Mar 19, 2026 | Oxtoby Andrew Executive | Grant | Stock Option (Right to Buy) | — | +222K | 222,000 0.93% of shares | low |
| Mar 19, 2026 | Hagen Brett R Executive | Grant | Stock Option (Right to Buy) | — | +61K | 60,800 0.26% of shares | low |
| Mar 19, 2026 | Feinsod Matthew Executive | Grant | Stock Option (Right to Buy) | — | +135K | 135,000 0.57% of shares | low |